These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15844442)

  • 21. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.
    Korhonen T; Turpeinen M; Tolonen A; Laine K; Pelkonen O
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):56-66. PubMed ID: 18356043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel hierarchical classification and visualization method for multiobjective optimization of drug properties: application to structure-activity relationship analysis of cytochrome P450 metabolism.
    Yamashita F; Hara H; Ito T; Hashida M
    J Chem Inf Model; 2008 Feb; 48(2):364-9. PubMed ID: 18211048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans.
    Thörn HA; Lundahl A; Schrickx JA; Dickinson PA; Lennernäs H
    Eur J Pharm Sci; 2011 Jun; 43(3):89-98. PubMed ID: 21447389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop.
    Shin YG; Le H; Khojasteh C; Hop CE
    Comb Chem High Throughput Screen; 2011 Nov; 14(9):811-23. PubMed ID: 21605066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors.
    Jensen BF; Vind C; Padkjaer SB; Brockhoff PB; Refsgaard HH
    J Med Chem; 2007 Feb; 50(3):501-11. PubMed ID: 17266202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of hops-containing products on human cytochrome P450-mediated metabolism.
    Foster BC; Arnason JT; Saleem A; Tam TW; Liu R; Mao J; Desjardins S
    J Agric Food Chem; 2011 May; 59(9):5159-63. PubMed ID: 21476568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
    Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
    Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.
    Yale SH; Glurich I
    J Altern Complement Med; 2005 Jun; 11(3):433-9. PubMed ID: 15992226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing small-molecule binding to cytochrome P450 2D6 and 2C9: An in silico protocol for generating toxicity alerts.
    Rossato G; Ernst B; Smiesko M; Spreafico M; Vedani A
    ChemMedChem; 2010 Dec; 5(12):2088-101. PubMed ID: 21038340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.
    Bostick CD; Hickey KM; Wollenberg LA; Flora DR; Tracy TS; Gannett PM
    Drug Metab Dispos; 2016 May; 44(5):741-9. PubMed ID: 26961240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.
    Ghosal A; Ramanathan R; Yuan Y; Hapangama N; Chowdhury SK; Kishnani NS; Alton KB
    Drug Metab Dispos; 2007 Dec; 35(12):2186-95. PubMed ID: 17827338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
    He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and validation of rapid computational filters for cyp2d6 and cyp3a4.
    Ekins S; Berbaum J; Harrison RK
    Drug Metab Dispos; 2003 Sep; 31(9):1077-80. PubMed ID: 12920160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
    Eng H; Obach RS
    Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.